Staff and patient views on nurse prescribing in the urgent-care setting

2015 ◽  
Vol 13 (12) ◽  
pp. 614-619 ◽  
Author(s):  
Amanda Armstrong
2018 ◽  
Vol Volume 7 ◽  
pp. 93-104 ◽  
Author(s):  
David Wright ◽  
Richard Adams ◽  
Jeanette Blacklock ◽  
Sarah Corlett ◽  
Rebecca Harmston ◽  
...  

1999 ◽  
Vol 12 (S1) ◽  
pp. 148-151 ◽  
Author(s):  
Christopher W. T. Mattern ◽  
Bradley J. Erickson ◽  
Bernard F. King ◽  
Trice W. Okryznski

2019 ◽  
Vol 8 (1) ◽  
pp. 101 ◽  
Author(s):  
Sara Torretta ◽  
Claudio Guastella ◽  
Paola Marchisio ◽  
Tal Marom ◽  
Samantha Bosis ◽  
...  

Sinonasal-related orbital infections (SROIs) are typically pediatric diseases that occur in 3–4% of children with acute rhinosinusitis. They are characterised by various clinical manifestations, such as peri-orbital and orbital cellulitis or orbital and sub-periosteal abscesses that may develop anteriorly or posteriorly to the orbital septum. Posterior septal complications are particularly dangerous, as they may lead to visual loss and life-threatening events, such as an intracranial abscess and cavernous sinus thrombosis. Given the possible risk of permanent visual loss due to optic neuritis or orbital nerve ischemia, SROIs are considered ophthalmic emergencies that need to be promptly recognised and treated in an urgent-care setting. The key to obtaining better clinical outcomes in children with SROIs is a multi-disciplinary assessment by pediatricians, otolaryngologists, ophthalmologists, radiologists, and in selected cases, neurosurgeons, neurologists, and infectious disease specialists. The aim of this paper is to provide an overview of the pathogenesis, clinical manifestations, diagnosis, and treatment of pediatric SROIs, and to make some practical recommendations for attending clinicians.


Author(s):  
Suchitra Rao ◽  
Angela Moss ◽  
Molly M Lamb ◽  
Edwin J Asturias

Abstract A test-negative case-control analysis of 1478 children aged 6 months to 8 years of age seeking care at an emergency/urgent care setting with influenza like illness during the 2016-17 and 2018-19 (H3N2 predominant) influenza seasons demonstrated that influenza vaccine effectiveness did not vary significantly by the prior seasons’ vaccination status. Clinical Trials Registration NCT02979626.


2015 ◽  
Vol 9 (1) ◽  
pp. 55-57
Author(s):  
Helen Williams ◽  
Agnes Kasprowicz ◽  
Murray Ellender ◽  
Mark Ashworth

Sign in / Sign up

Export Citation Format

Share Document